Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regen BioPharma (RGBP) Return on Equity (2016 - 2025)

Regen BioPharma (RGBP) has disclosed Return on Equity for 12 consecutive years, with 0.12% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity fell 7.0% to 0.12% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.12%, a 7.0% decrease, with the full-year FY2025 number at 0.22%, up 9.0% from a year prior.
  • Return on Equity was 0.12% for Q4 2025 at Regen BioPharma, down from 0.21% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.21% in Q3 2025 to a low of 0.01% in Q1 2022.
  • A 5-year average of 0.1% and a median of 0.1% in 2024 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: rose 15bps in 2023, then decreased -8bps in 2024.
  • Regen BioPharma's Return on Equity stood at 0.04% in 2021, then skyrocketed by 233bps to 0.13% in 2022, then tumbled by -38bps to 0.08% in 2023, then surged by 141bps to 0.19% in 2024, then plummeted by -38bps to 0.12% in 2025.
  • Per Business Quant, the three most recent readings for RGBP's Return on Equity are 0.12% (Q4 2025), 0.21% (Q3 2025), and 0.17% (Q2 2025).